Literature DB >> 17145145

Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes.

Birgit Romberg1, Josbert M Metselaar, Lajos Baranyi, Cor J Snel, Rolf Bünger, Wim E Hennink, Janos Szebeni, Gert Storm.   

Abstract

Poly(amino acid)s (PAAs) were evaluated as coating polymers for long-circulating liposomes. The pharmacokinetics of PAA-coated liposomes were assessed in rats. Prolonged circulation times were obtained, comparable to those reported for poly(ethylene glycol) (PEG)-liposomes. Besides, the enzymatic degradability of PAAs was studied. PAAs - in free as well as liposome-associated form - are degradable by proteases, which is beneficial for reducing the risks of accumulation in vivo. Furthermore, complement activation by PAA-liposomes was evaluated in vitro and in vivo. Like other liposome types, they appear to activate the complement system. However, a role of endotoxin contamination of the PAA-liposome formulations used cannot be excluded in our complement activation studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145145     DOI: 10.1016/j.ijpharm.2006.11.018

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 2.  Recent advances in stealth coating of nanoparticle drug delivery systems.

Authors:  Zohreh Amoozgar; Yoon Yeo
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-01-09

Review 3.  Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases.

Authors:  Sureshbabu Ram Kumar Pandian; Kevin Kumar Vijayakumar; Sankaranarayanan Murugesan; Selvaraj Kunjiappan
Journal:  Heliyon       Date:  2022-06-04

Review 4.  Designer lipids for drug delivery: from heads to tails.

Authors:  Aditya G Kohli; Paul H Kierstead; Vincent J Venditto; Colin L Walsh; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-06       Impact factor: 9.776

5.  In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines.

Authors:  Lilach Vaks; Itai Benhar
Journal:  J Nanobiotechnology       Date:  2011-12-20       Impact factor: 10.435

6.  Surface engineering of liposomes for stealth behavior.

Authors:  Okhil K Nag; Vibhudutta Awasthi
Journal:  Pharmaceutics       Date:  2013-10-25       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.